
statnews.com/2024/09/25/chr… new chronic urticaria therapy: 25% of patients who started the study on barzolvolimab stopped treatment during the trial, changes in hair and skin color reported
English
Ves Dimov, M.D.
10.6K posts

@Allergy
Allergist/Immunologist at Cleveland Clinic. Associate Professor at FAU, https://t.co/vGug2JvujH. Past President of Florida Allergy Society. Disclaimer at URL.



